NEW YORK-- Tripp Levy PLLC, a leading national securities law firm, is investigating the Board of Directors of Physicians Formula Holdings, Inc. (“Physicians Formula” or the “Company”) (NasdaqGS: FACE) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to affiliates of Swander Pace Capital.
Under the terms of the transaction, Physicians Formula shareholders will receive $4.25 per share of Physicians Formula stock they own. The transaction has a total approximate value of $65 million. The investigation concerns whether the Physicians Formula Board of Directors breached their fiduciary duties to stockholders by failing to adequately shop the Company before entering into this transaction and whether Swander Pace Capital is underpaying for Physicians Formula shares, thus unlawfully harming Physicians Formula stockholders. In particular, at least one analyst set a price target for Physicians Formula stock at $5.00 per share.
If you own common stock in Physicians Formula and wish to obtain additional information, please contact us toll free at 877-772-3975 or email at email@example.com.
Tripp Levy PLLC is a national firm with offices throughout the country. The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits and has successfully recovered multimillion-dollar damages awards on behalf of investors.